Clinical Trial Update: A Phase I Study of SHR-3836 in Patients With Multiple Myeloma [Phase 1]

View source ↗

Summary

A Phase I clinical trial of SHR-3836 for multiple myeloma is listed as not yet recruiting. The sponsor is Shanghai Hengrui Pharmaceutical Co., Ltd.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• SHR-3836

Snippet

Sponsor: Shanghai Hengrui Pharmaceutical Co., Ltd. | Conditions: Multiple Myeloma | Phase 1 | Status: NOT_YET_RECRUITING